These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15224146)
1. [Vasonatrin peptide attenuates the enhancement of electrically-induced intracellular calcium transient by isoproterenol in rat cardiac myocytes]. Guo HT; Zhu MZ; Zhang RH; Bi H; Zhang B; Zhang HF; Yu J; Lu SY; Pei JM Sheng Li Xue Bao; 2004 Jun; 56(3):335-40. PubMed ID: 15224146 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts. Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207 [TBL] [Abstract][Full Text] [Related]
3. [Vasonatrin peptide attenuates hypoxia-induced increase in [Ca(2+)] (i) of culured rat cardiac fibroblasts]. Guo HT; Zhu MZ; Lu SY; Yu J; Dong MQ; Gao Z; Shi PT Sheng Li Xue Bao; 2001 Aug; 53(4):286-90. PubMed ID: 11930207 [TBL] [Abstract][Full Text] [Related]
4. [Vasorelaxing role of vasonatrin peptide in human intramammary artery in vitro]. Yu J; Zhu MZ; Wei GZ; Chen BY; Lu SY; Kang YF; Guo HT; Ma H; Dong MQ Sheng Li Xue Bao; 2003 Apr; 55(2):187-90. PubMed ID: 12715109 [TBL] [Abstract][Full Text] [Related]
5. [Effect of vasonatrin peptide on the Ca2+ activated K+ channels of vascular smooth muscle cells isolated from rat mesentery arteries]. Yu J; Zhu MZ; Liu LB; Chen BY; Lu SY; Zhou JJ; Fu ZJ Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):94-7. PubMed ID: 21186590 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells. Lu SY; Wang DS; Zhu MZ; Zhang QH; Hu YZ; Pei JM Life Sci; 2005 May; 77(1):28-38. PubMed ID: 15848216 [TBL] [Abstract][Full Text] [Related]
7. [Study on the mechanism of how vasonatrin peptide can attenuate the growth-promoting effect of hypoxia in cardiac fibroblasts]. Yu J; Zhu MZ; Cheng BY; Lu SY; Dong MQ Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Feb; 19(1):8-11. PubMed ID: 21207845 [TBL] [Abstract][Full Text] [Related]
8. Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries. Woodard GE; Li X; Brown J; Rosado JA Regul Pept; 2005 Jul; 129(1-3):183-9. PubMed ID: 15927715 [TBL] [Abstract][Full Text] [Related]
9. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiomyocyte contractile/relaxation by MN9202 and mechanisms involved. Zhu X; Zhu X; Niu X; Pei J; Xiong L; Chen S; Lu SY; Wei J; Xing B; Liu L; Mei Q; Zhu M; Kaye AD Arch Med Res; 2008 Jul; 39(5):489-95. PubMed ID: 18514093 [TBL] [Abstract][Full Text] [Related]
12. [Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes]. Lu SY; Zhu MZ; Guo HT; Yu J; Wei QM Sheng Li Xue Bao; 2002 Feb; 54(1):7-11. PubMed ID: 11930233 [TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes. Lonardo G; Cerbai E; Casini S; Giunti G; Bonacchi M; Battaglia F; Fiorani B; Stefano PL; Sani G; Mugelli A Cardiovasc Res; 2004 Aug; 63(3):528-36. PubMed ID: 15276478 [TBL] [Abstract][Full Text] [Related]
14. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400 [TBL] [Abstract][Full Text] [Related]
15. Vasorelaxing action of vasonatrin peptide is associated with activation of large-conductance Ca(2+)-activated potassium channels in vascular smooth muscle cells. Yu J; Zhu M; Fu Z; Zhu X; Zhao Y; Chen B Physiol Res; 2010; 59(2):187-194. PubMed ID: 19537928 [TBL] [Abstract][Full Text] [Related]
16. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Fischmeister R; Castro L; Abi-Gerges A; Rochais F; Vandecasteele G Comp Biochem Physiol A Mol Integr Physiol; 2005 Oct; 142(2):136-43. PubMed ID: 15927494 [TBL] [Abstract][Full Text] [Related]
17. Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts. Yong QC; Pan TT; Hu LF; Bian JS J Mol Cell Cardiol; 2008 Apr; 44(4):701-10. PubMed ID: 18329040 [TBL] [Abstract][Full Text] [Related]
18. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901 [TBL] [Abstract][Full Text] [Related]
19. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. Kaneki H; Kurokawa M; Ide H J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543 [TBL] [Abstract][Full Text] [Related]
20. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]